F. Daniel Armstrong, Ph.D., West Virginia University

Professor & Associate Chair, Pediatrics & Director, Mailman Center for Child Development

  • 4564 Citations
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Self Communities: Allapattah, Overtown, Liberty City, Goulds, Homestead, Florida City; 3 counties (Miami-Dade, Broward, Palm Beach for sickle cell disease); Countries: Paraguay, Japan, Argentina, Abu Dhabi; Diverse Groups Worked With (USA): African American, Haitian-American, HIspanic, developmental and intellectual disabilities

Research interests

  • pediatric multicultural health
  • cancer health disparities
  • sickle cell disease

Fingerprint Dive into the research topics where F. Daniel Armstrong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    COVID-19: overcoming the challenges faced by individuals with autism and their families

    Eshraghi, A. A., Li, C., Alessandri, M., Messinger, D. S., Eshraghi, R. S., Mittal, R. & Armstrong, F. D., Jun 2020, In : The Lancet Psychiatry. 7, 6, p. 481-483 3 p.

    Research output: Contribution to journalLetter

    Open Access
    3 Scopus citations

    Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study

    Barredo, J. C., Hastings, C., Lu, X., Devidas, M., Chen, Y., Armstrong, D., Winick, N., Wood, B. L., Yanofsky, R., Loh, M., Gastier-Foster, J. M., Jorstad, D. T., Marcus, R., Ritchey, K., Carrol, W. L. & Hunger, S. P., May 2018, In : Pediatric Blood and Cancer. 65, 5, e26928.

    Research output: Contribution to journalArticle

  • 10 Scopus citations

    Neurocognitive functioning of children treated for high-risk B-acute lymphoblastic leukemia randomly assigned to different methotrexate and corticosteroid treatment strategies: A report from the children's oncology group

    Hardy, K. K., Embry, L., Kairalla, J. A., Helian, S., Devidas, M., Armstrong, D., Hunger, S., Carroll, W. L., Larsen, E., Raetz, E. A., Loh, M. L., Yang, W., Relling, M. V., Noll, R. B. & Winick, N., Aug 10 2017, In : Journal of Clinical Oncology. 35, 23, p. 2700-2707 8 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations

    Reply to I.J. Cohen

    Hardy, K. K., Embry, L. M., Kairalla, J. A., Helian, S., Devidas, M., Armstrong, F. D., Hunger, S., Carroll, W. L., Larsen, E., Raetz, E. A., Loh, M. L., Yang, W., Relling, M. V., Noll, R. B. & Winick, N., Dec 10 2017, In : Journal of Clinical Oncology. 35, 35, p. 3989-3990 2 p.

    Research output: Contribution to journalLetter